Strengthening the EU's pandemic preparedness with a new approach for antiviral development
--
This project has received funding from the European Health and Digital Executive Agency under grant number 101137419.
Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.
Company Details
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.evamobs.eu
- Competitors
- Evermob, BioPlaTTAR, Fundación ”la Caixa”, AICIB - Agência de Investigação Clínica e Inovação Biomédica, Pasilac, Labialfarma, Laboratórios Dermatológicos de Uriage Portugal, European Health and Digital Executive Agency (HaDEA), GIMM, SHIELD - Molecular Strategies against Viral Entry and Glycan Shielding.
Evamobs Questions
Evamobs's website is http://www.evamobs.eu
Evamobs's LinkedIn profile is https://www.linkedin.com/company/evamobs
Evamobs's industry is
Research Services
Evamobs's top competitors are
Evermob,
Bioplattar,
Fundación ”la Caixa”,
Aicib - Agência De Investigação Clínica E Inovação Biomédica,
Pasilac,
Labialfarma,
Laboratórios Dermatológicos De Uriage Portugal,
European Health And Digital Executive Agency (Hadea),
Gimm,
Shield - Molecular Strategies Against Viral Entry And Glycan Shielding.
Evamobs's categories are Research Services
